Meili Nanotechnology
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- Undisclosed
Investors
- 1
About Meili Nanotechnology
Established in 2017 and based in Shenzhen, China, Meili Nanotechnology operates as a nanopore early cancer detection devices developer that provides commercial gene sequencing instruments and supporting reagents. The core research team comes from Ohio State University, University of Washington, University of Jena, Germany and University of Chinese Academy of Sciences. The company cooperates with institute of physics of Chinese Academy of Sciences, Shenzhen University of Technology and Xiangya Hospital of Central South University, etc. In March 2021, the company cooperates with Changde high-tech zone. In November 2022, it was rewarded as the top 10 most growing biotech companies. The company combines nanopore gene sequencing technology with pathogen detection. Products cover many testing fields, including immunological, microbiological, biochemical, molecular and coagulation, etc. Its products include MePore single-channel sequencing systems for research users, MeMob gene sequencers, MeZero pA class current amplifier and multichannel microfluidic chips.
Who invested in Meili Nanotechnology
1 investor across 1 round
See all investors in Meili Nanotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 17, 2018
Amount
Undisclosed
Investors
Questions about Meili Nanotechnology
Who invested in Meili Nanotechnology?
Meili Nanotechnology has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Meili Nanotechnology raised?
Meili Nanotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Meili Nanotechnology last raise money?
Meili Nanotechnology's most recent round on record is a Series A, in Jul 2018.
What does Meili Nanotechnology do?
Established in 2017 and based in Shenzhen, China, Meili Nanotechnology operates as a nanopore early cancer detection devices developer that provides commercial gene sequencing instruments and supporting reagents.
Where is Meili Nanotechnology headquartered?
Meili Nanotechnology is headquartered in Shenzhen, China.
Which VCs invest in companies like Meili Nanotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Meili Nanotechnology's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Meili Nanotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.